Elanco Animal Health Inc. has received the first-ever Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for Credelio™ (lotilaner) to treat New World screwworm $(NWS)$ infestations in dogs. This authorization provides veterinarians and pet owners with a treatment option in advance of the fly being detected in the U.S. The EUA was granted based on published research demonstrating that Credelio achieved 100% efficacy against NWS larvae within 24 hours in naturally infested dogs. No other organizations were mentioned as recipients of this regulatory approval.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE06723) on October 24, 2025, and is solely responsible for the information contained therein.